ArticleFrontiers in medicine2025
Lower bioelectrical impedance phase angle is associated with COPD and is a marker for increased risks in elderly COPD patients.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Association of phase angle with malnutrition and sarcopenia in interstitial lung disease: a cross-sectional analysis of body composition and functional decline.BMC pulmonary medicine · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The phase angle (PhA), derived from bioelectrical impedance analysis (BIA), serves as an indicator of cellular health and body composition. While associated with muscle strength and exercise capacity in various conditions, its clinical relevance in chronic obstructive pulmonary disease (COPD) requires further characterization. This study aimed to evaluate the relationship between PhA, muscle strength, and physical function among individuals with COPD. Methods: Between June 2024 and August 2025, 112 male patients with COPD and 20 healthy male controls were enrolled in this cross-sectional study. Assessments included pulmonary function, body composition via BIA, handgrip strength, knee extension strength, walking speed, and other clinical indicators. Relationships were analyzed using multivariable linear and least absolute shrinkage and selection operator (LASSO) regression models. Results: PhA values were significantly lower in COPD patients than in healthy controls. Stratification of COPD patients by PhA revealed that a lower PhA was associated with progressively worse muscle strength, exercise capacity, and other clinical markers. Multivariable linear regression analyses demonstrated that a lower PhA was independently associated with slower walking speed ( Conclusion: In this cross-sectional study, a lower PhA is independently associated with muscle weakness and impaired physical performance in men with COPD. These findings suggest that PhA may serve as a useful biomarker for assessing nutritional and functional status in this population. However, the cross-sectional design precludes causal inference, and the diagnostic utility of PhA for COPD itself is not established.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.